ED
BAP icon

Exane Derivatives’s Credicorp BAP Stock Holding History

Exane Derivatives’s Portfolio BAP Stock Details BAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1
Closed -$158 – 580
2016
Q4 		$158 Hold
1
– – ﹤0.01% 516
2016
Q3 		$152 Hold
1
– – ﹤0.01% 519
2016
Q2 		$154 Sell
1
-106
-99% -$15.2K ﹤0.01% 452
2016
Q1 		$14K Hold
107
– – ﹤0.01% 394
2015
Q4 		$10.4K Sell
107
-95
-47% -$10.3K ﹤0.01% 324
2015
Q3 		$21.5K Sell
202
-29
-13% -$3.5K ﹤0.01% 311
2015
Q2 		$32.1K Hold
231
– – ﹤0.01% 315
2015
Q1 		$32.5K Buy
231
+105
+83% +$15.4K ﹤0.01% 341
2014
Q4 		$20.2K Buy
+126
New +$20K ﹤0.01% 387

Other funds holding BAP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM

Exane Derivatives's BAP Position: Q1 2017 in Review

Exane Derivatives sold out of Credicorp (BAP) in Q1 2017, closing a stake of 1 share — an estimated $158 sold.

Exane Derivatives first reported a position in BAP in Q4 2014 and held it in 9 quarters. The position peaked at $32.5K in Q1 2015. 285 funds tracked by Wall St. Rank hold BAP as of Q1 2017.

  • Exane Derivatives reported no remaining Credicorp position as of Q1 2017 after selling out during the quarter.
  • Exane Derivatives sold 1 Credicorp share in Q1 2017, an estimated $158.
  • Exane Derivatives first reported a position in Credicorp in Q4 2014 and held it in 9 quarters.
  • Exane Derivatives's Credicorp position peaked at $32.5K in Q1 2015.
  • 285 funds tracked by Wall St. Rank held Credicorp as of Q1 2017.

Based on Exane Derivatives's 13F filing for Q1 2017, filed 28 Apr 2017.